November 26, 2019 โ The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a ...
November 11, 2019 โ Although common femoral artery (CFA) endarterectomy is still considered the gold standard treatment ...
November 7, 2019 โ Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...
November 4, 2019 โ Abbott is recalling its CentriMag Acute Circulatory Support System due to a calibration system error ...
October 11, 2019 โ The ultra-thin Supraflex drug-eluting stent (DES) from SMT maintained numerically lower outcomes at ...
October 9, 2019 โ Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has received ...
October 4, 2019 โ Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve ...
October 3, 2019 โ Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with ...
October 3, 2019 โ The three-year results from the COAPT Trial demonstrated that reducing severe secondary mitral ...
October 2, 2019 โ The Abbott Portico FDA investigational device exemption (IDE) study found that 30-day safety and one ...